Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes

Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Psychosomatics (Washington, D.C.) D.C.), 2014-07, Vol.55 (4), p.343-351
Hauptverfasser: Lee, Aaron A., M.S, McKibbin, Christine L., Ph.D, Bourassa, Katelynn A., B.A, Wykes, Thomas L., M.S, Kitchen Andren, Katherine A., M.S
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 351
container_issue 4
container_start_page 343
container_title Psychosomatics (Washington, D.C.)
container_volume 55
creator Lee, Aaron A., M.S
McKibbin, Christine L., Ph.D
Bourassa, Katelynn A., B.A
Wykes, Thomas L., M.S
Kitchen Andren, Katherine A., M.S
description Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabetic complications and depressive symptom severity as predictors of disability and evaluate depressive symptom severity as a mediator of the relationship between diabetic complications and disability in a sample of 62 adults with schizophrenia and type 2 diabetes. Methods Two- and 3-step sequential regression models were used to evaluate the relationship of depression and number of diabetic complications with disability. Path analysis with bootstrapping was used to evaluate depressive symptom severity as a mediator of the relationship between complications and disability. Results Diabetic complications significantly predicted disability scores when controlling for age, gender, socioeconomic status, hemoglobin A1C, positive symptom severity, and negative symptom severity. The addition of depression severity scores resulted in a significant increase in explained variance in disability scores. In the final model, only depression severity scores were significantly associated with disability scores. The full model accounted for 56.2% of the variance in disability scores. Path analysis revealed a significant indirect association of diabetic complications to disability through depression severity scores while controlling for all covariates. The association between complications and disability was nonsignificant when depressive symptom severity was included in the model. Conclusions Depressive symptoms may present an important and tractable target for interventions aimed at reducing disability in people with schizophrenia and type 2 diabetes.
doi_str_mv 10.1016/j.psym.2013.12.015
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10066802</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0033318213002478</els_id><sourcerecordid>1543678996</sourcerecordid><originalsourceid>FETCH-LOGICAL-c558t-48356fc9e8b73fc8618c8f9a2e2e04b5144dc50691044ae05d738456c3013d6f3</originalsourceid><addsrcrecordid>eNpVkk9v1DAQxSMEokvhC3BAuSBxIGFsx473Aqq25Y9UCaQWcbQcZ9L1ktipna2UfnocdilwsuT5zZvRe5NlLwmUBIh4tyvHOA8lBcJKQksg_FG2IrziRU1BPM5WAIwVjEh6kj2LcQcAnHDxNDuhVc0JIXSV-XMcA8ZovXubn1vd4GRNvvHD2Fujp_Qdc-3aVIq6sb2d5vxs8O4m_4YhLsUfdtouvA-NbfMrs7X3ftwGdFb_bryeR8zpURrj8-xJp_uIL47vafb948X15nNx-fXTl83ZZWE4l1NRScZFZ9Yom5p1RgoijezWmiJFqBpOqqo1HMSaQFVpBN7WTFZcGJbMaEXHTrMPB91x3wzYGnRT0L0agx10mJXXVv1fcXarbvydIgBCSKBJ4c1RIfjbPcZJDTYa7Hvt0O-jSkYzUcv1WiSUHlATfIwBu4c5BNQSldqpJSq1RKUIVSmq1PTq3w0fWv5kk4DXR0BHo_suaGds_MslU6DiC_f-wGHy885iUKa3LqXX_8QZ487vg0tWK6JimqyulqtYjoIwgDRMsl8b-rNw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1543678996</pqid></control><display><type>article</type><title>Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Lee, Aaron A., M.S ; McKibbin, Christine L., Ph.D ; Bourassa, Katelynn A., B.A ; Wykes, Thomas L., M.S ; Kitchen Andren, Katherine A., M.S</creator><creatorcontrib>Lee, Aaron A., M.S ; McKibbin, Christine L., Ph.D ; Bourassa, Katelynn A., B.A ; Wykes, Thomas L., M.S ; Kitchen Andren, Katherine A., M.S</creatorcontrib><description>Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabetic complications and depressive symptom severity as predictors of disability and evaluate depressive symptom severity as a mediator of the relationship between diabetic complications and disability in a sample of 62 adults with schizophrenia and type 2 diabetes. Methods Two- and 3-step sequential regression models were used to evaluate the relationship of depression and number of diabetic complications with disability. Path analysis with bootstrapping was used to evaluate depressive symptom severity as a mediator of the relationship between complications and disability. Results Diabetic complications significantly predicted disability scores when controlling for age, gender, socioeconomic status, hemoglobin A1C, positive symptom severity, and negative symptom severity. The addition of depression severity scores resulted in a significant increase in explained variance in disability scores. In the final model, only depression severity scores were significantly associated with disability scores. The full model accounted for 56.2% of the variance in disability scores. Path analysis revealed a significant indirect association of diabetic complications to disability through depression severity scores while controlling for all covariates. The association between complications and disability was nonsignificant when depressive symptom severity was included in the model. Conclusions Depressive symptoms may present an important and tractable target for interventions aimed at reducing disability in people with schizophrenia and type 2 diabetes.</description><identifier>ISSN: 0033-3182</identifier><identifier>EISSN: 1545-7206</identifier><identifier>DOI: 10.1016/j.psym.2013.12.015</identifier><identifier>PMID: 24751112</identifier><language>eng</language><publisher>Arlington, VA: American Psychiatric Publishing</publisher><subject>Adult and adolescent clinical studies ; Biological and medical sciences ; Depression ; Depression - etiology ; Diabetes Complications - etiology ; Diabetes Mellitus, Type 2 - complications ; Diabetes Mellitus, Type 2 - psychology ; Diabetes. Impaired glucose tolerance ; Disabled Persons - psychology ; Disabled Persons - statistics &amp; numerical data ; Endocrine pancreas. Apud cells (diseases) ; Endocrinopathies ; Etiopathogenesis. Screening. Investigations. Target tissue resistance ; Female ; Humans ; Internal Medicine ; Male ; Medical sciences ; Middle Aged ; Miscellaneous ; Mood disorders ; Psychiatric Status Rating Scales ; Psychiatry ; Psychology. Psychoanalysis. Psychiatry ; Psychopathology. Psychiatry ; Psychoses ; Risk Factors ; Schizophrenia ; Schizophrenia - complications</subject><ispartof>Psychosomatics (Washington, D.C.), 2014-07, Vol.55 (4), p.343-351</ispartof><rights>Academy of Psychosomatic Medicine</rights><rights>2015 INIST-CNRS</rights><rights>Copyright © 2014 Academy of Psychosomatic Medicine. Published by Elsevier Inc. All rights reserved.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c558t-48356fc9e8b73fc8618c8f9a2e2e04b5144dc50691044ae05d738456c3013d6f3</citedby><cites>FETCH-LOGICAL-c558t-48356fc9e8b73fc8618c8f9a2e2e04b5144dc50691044ae05d738456c3013d6f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28610452$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24751112$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lee, Aaron A., M.S</creatorcontrib><creatorcontrib>McKibbin, Christine L., Ph.D</creatorcontrib><creatorcontrib>Bourassa, Katelynn A., B.A</creatorcontrib><creatorcontrib>Wykes, Thomas L., M.S</creatorcontrib><creatorcontrib>Kitchen Andren, Katherine A., M.S</creatorcontrib><title>Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes</title><title>Psychosomatics (Washington, D.C.)</title><addtitle>Psychosomatics</addtitle><description>Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabetic complications and depressive symptom severity as predictors of disability and evaluate depressive symptom severity as a mediator of the relationship between diabetic complications and disability in a sample of 62 adults with schizophrenia and type 2 diabetes. Methods Two- and 3-step sequential regression models were used to evaluate the relationship of depression and number of diabetic complications with disability. Path analysis with bootstrapping was used to evaluate depressive symptom severity as a mediator of the relationship between complications and disability. Results Diabetic complications significantly predicted disability scores when controlling for age, gender, socioeconomic status, hemoglobin A1C, positive symptom severity, and negative symptom severity. The addition of depression severity scores resulted in a significant increase in explained variance in disability scores. In the final model, only depression severity scores were significantly associated with disability scores. The full model accounted for 56.2% of the variance in disability scores. Path analysis revealed a significant indirect association of diabetic complications to disability through depression severity scores while controlling for all covariates. The association between complications and disability was nonsignificant when depressive symptom severity was included in the model. Conclusions Depressive symptoms may present an important and tractable target for interventions aimed at reducing disability in people with schizophrenia and type 2 diabetes.</description><subject>Adult and adolescent clinical studies</subject><subject>Biological and medical sciences</subject><subject>Depression</subject><subject>Depression - etiology</subject><subject>Diabetes Complications - etiology</subject><subject>Diabetes Mellitus, Type 2 - complications</subject><subject>Diabetes Mellitus, Type 2 - psychology</subject><subject>Diabetes. Impaired glucose tolerance</subject><subject>Disabled Persons - psychology</subject><subject>Disabled Persons - statistics &amp; numerical data</subject><subject>Endocrine pancreas. Apud cells (diseases)</subject><subject>Endocrinopathies</subject><subject>Etiopathogenesis. Screening. Investigations. Target tissue resistance</subject><subject>Female</subject><subject>Humans</subject><subject>Internal Medicine</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Miscellaneous</subject><subject>Mood disorders</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychiatry</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopathology. Psychiatry</subject><subject>Psychoses</subject><subject>Risk Factors</subject><subject>Schizophrenia</subject><subject>Schizophrenia - complications</subject><issn>0033-3182</issn><issn>1545-7206</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkk9v1DAQxSMEokvhC3BAuSBxIGFsx473Aqq25Y9UCaQWcbQcZ9L1ktipna2UfnocdilwsuT5zZvRe5NlLwmUBIh4tyvHOA8lBcJKQksg_FG2IrziRU1BPM5WAIwVjEh6kj2LcQcAnHDxNDuhVc0JIXSV-XMcA8ZovXubn1vd4GRNvvHD2Fujp_Qdc-3aVIq6sb2d5vxs8O4m_4YhLsUfdtouvA-NbfMrs7X3ftwGdFb_bryeR8zpURrj8-xJp_uIL47vafb948X15nNx-fXTl83ZZWE4l1NRScZFZ9Yom5p1RgoijezWmiJFqBpOqqo1HMSaQFVpBN7WTFZcGJbMaEXHTrMPB91x3wzYGnRT0L0agx10mJXXVv1fcXarbvydIgBCSKBJ4c1RIfjbPcZJDTYa7Hvt0O-jSkYzUcv1WiSUHlATfIwBu4c5BNQSldqpJSq1RKUIVSmq1PTq3w0fWv5kk4DXR0BHo_suaGds_MslU6DiC_f-wGHy885iUKa3LqXX_8QZ487vg0tWK6JimqyulqtYjoIwgDRMsl8b-rNw</recordid><startdate>20140701</startdate><enddate>20140701</enddate><creator>Lee, Aaron A., M.S</creator><creator>McKibbin, Christine L., Ph.D</creator><creator>Bourassa, Katelynn A., B.A</creator><creator>Wykes, Thomas L., M.S</creator><creator>Kitchen Andren, Katherine A., M.S</creator><general>American Psychiatric Publishing</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20140701</creationdate><title>Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes</title><author>Lee, Aaron A., M.S ; McKibbin, Christine L., Ph.D ; Bourassa, Katelynn A., B.A ; Wykes, Thomas L., M.S ; Kitchen Andren, Katherine A., M.S</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c558t-48356fc9e8b73fc8618c8f9a2e2e04b5144dc50691044ae05d738456c3013d6f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult and adolescent clinical studies</topic><topic>Biological and medical sciences</topic><topic>Depression</topic><topic>Depression - etiology</topic><topic>Diabetes Complications - etiology</topic><topic>Diabetes Mellitus, Type 2 - complications</topic><topic>Diabetes Mellitus, Type 2 - psychology</topic><topic>Diabetes. Impaired glucose tolerance</topic><topic>Disabled Persons - psychology</topic><topic>Disabled Persons - statistics &amp; numerical data</topic><topic>Endocrine pancreas. Apud cells (diseases)</topic><topic>Endocrinopathies</topic><topic>Etiopathogenesis. Screening. Investigations. Target tissue resistance</topic><topic>Female</topic><topic>Humans</topic><topic>Internal Medicine</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Miscellaneous</topic><topic>Mood disorders</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychiatry</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopathology. Psychiatry</topic><topic>Psychoses</topic><topic>Risk Factors</topic><topic>Schizophrenia</topic><topic>Schizophrenia - complications</topic><toplevel>online_resources</toplevel><creatorcontrib>Lee, Aaron A., M.S</creatorcontrib><creatorcontrib>McKibbin, Christine L., Ph.D</creatorcontrib><creatorcontrib>Bourassa, Katelynn A., B.A</creatorcontrib><creatorcontrib>Wykes, Thomas L., M.S</creatorcontrib><creatorcontrib>Kitchen Andren, Katherine A., M.S</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Psychosomatics (Washington, D.C.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lee, Aaron A., M.S</au><au>McKibbin, Christine L., Ph.D</au><au>Bourassa, Katelynn A., B.A</au><au>Wykes, Thomas L., M.S</au><au>Kitchen Andren, Katherine A., M.S</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes</atitle><jtitle>Psychosomatics (Washington, D.C.)</jtitle><addtitle>Psychosomatics</addtitle><date>2014-07-01</date><risdate>2014</risdate><volume>55</volume><issue>4</issue><spage>343</spage><epage>351</epage><pages>343-351</pages><issn>0033-3182</issn><eissn>1545-7206</eissn><abstract>Background People with schizophrenia are at increased risk for type 2 diabetes, its complications, depression, and disability. However, little is known about the interrelationships of these 3 factors in adults with schizophrenia and type 2 diabetes. Objective We sought to assess the number of diabetic complications and depressive symptom severity as predictors of disability and evaluate depressive symptom severity as a mediator of the relationship between diabetic complications and disability in a sample of 62 adults with schizophrenia and type 2 diabetes. Methods Two- and 3-step sequential regression models were used to evaluate the relationship of depression and number of diabetic complications with disability. Path analysis with bootstrapping was used to evaluate depressive symptom severity as a mediator of the relationship between complications and disability. Results Diabetic complications significantly predicted disability scores when controlling for age, gender, socioeconomic status, hemoglobin A1C, positive symptom severity, and negative symptom severity. The addition of depression severity scores resulted in a significant increase in explained variance in disability scores. In the final model, only depression severity scores were significantly associated with disability scores. The full model accounted for 56.2% of the variance in disability scores. Path analysis revealed a significant indirect association of diabetic complications to disability through depression severity scores while controlling for all covariates. The association between complications and disability was nonsignificant when depressive symptom severity was included in the model. Conclusions Depressive symptoms may present an important and tractable target for interventions aimed at reducing disability in people with schizophrenia and type 2 diabetes.</abstract><cop>Arlington, VA</cop><pub>American Psychiatric Publishing</pub><pmid>24751112</pmid><doi>10.1016/j.psym.2013.12.015</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0033-3182
ispartof Psychosomatics (Washington, D.C.), 2014-07, Vol.55 (4), p.343-351
issn 0033-3182
1545-7206
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10066802
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult and adolescent clinical studies
Biological and medical sciences
Depression
Depression - etiology
Diabetes Complications - etiology
Diabetes Mellitus, Type 2 - complications
Diabetes Mellitus, Type 2 - psychology
Diabetes. Impaired glucose tolerance
Disabled Persons - psychology
Disabled Persons - statistics & numerical data
Endocrine pancreas. Apud cells (diseases)
Endocrinopathies
Etiopathogenesis. Screening. Investigations. Target tissue resistance
Female
Humans
Internal Medicine
Male
Medical sciences
Middle Aged
Miscellaneous
Mood disorders
Psychiatric Status Rating Scales
Psychiatry
Psychology. Psychoanalysis. Psychiatry
Psychopathology. Psychiatry
Psychoses
Risk Factors
Schizophrenia
Schizophrenia - complications
title Depression, Diabetic Complications and Disability Among Persons With Comorbid Schizophrenia and Type 2 Diabetes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T12%3A02%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Depression,%20Diabetic%20Complications%20and%20Disability%20Among%20Persons%20With%20Comorbid%20Schizophrenia%20and%20Type%202%20Diabetes&rft.jtitle=Psychosomatics%20(Washington,%20D.C.)&rft.au=Lee,%20Aaron%20A.,%20M.S&rft.date=2014-07-01&rft.volume=55&rft.issue=4&rft.spage=343&rft.epage=351&rft.pages=343-351&rft.issn=0033-3182&rft.eissn=1545-7206&rft_id=info:doi/10.1016/j.psym.2013.12.015&rft_dat=%3Cproquest_pubme%3E1543678996%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1543678996&rft_id=info:pmid/24751112&rft_els_id=1_s2_0_S0033318213002478&rfr_iscdi=true